Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Landscape Professional Research Report 2025

Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Landscape Professional Research Report 2025

Research Summary

Chemotherapy-induced nausea and vomiting (CINV) drugs are medications specifically designed to prevent or alleviate the symptoms of nausea and vomiting caused by chemotherapy treatments. Chemotherapy, a common cancer treatment, can trigger the release of certain chemicals in the body that stimulate the vomiting center in the brain, leading to CINV in many patients. CINV drugs work by targeting receptors in the brain and gastrointestinal tract, suppressing the signals that trigger nausea and vomiting. These drugs can be given before, during, or after chemotherapy sessions, and they are essential in improving the quality of life for cancer patients by reducing the distressing side effects associated with chemotherapy. CINV drugs are available in various forms, including oral tablets, injections, and patches, and their use is determined based on the individual patient＇s condition, the type of chemotherapy regimen, and the risk of developing CINV. Effective management of CINV is crucial to support cancer patients throughout their treatment and help them complete their therapy successfully.

According to DIResearch's in-depth investigation and research, the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs include Heron Therapeutics, Merck, Eisai, Mundipharma, Qilu Pharma, Teva, Novartis, Roche, Mylan, Baxter, GSK, Helsinn, Southwest Pharma, Haisco, Sun Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Include:

Heron Therapeutics

Merck

Eisai

Mundipharma

Qilu Pharma

Teva

Novartis

Roche

Mylan

Baxter

GSK

Helsinn

Southwest Pharma

Haisco

Sun Pharma

Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Segment Include:

5-HT3 Inhibitors

NK1 Inhibitors

Others

Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Application Include:

Acute CINV

Delayed CINV

Breakthrough CINV

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry PESTEL Analysis

Chapter 3: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Porter’s Five Forces Analysis

Chapter 4: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Regional Market Size and Forecast Analysis

Chapter 5: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources